Search Results

You are looking at 31 - 40 of 152 items for :

Clear All
Full access

Matthew D. Galsky, Harry W. Herr and Dean F. Bajorin

cancer outcomes after radical cystectomy . Urology 2003 ; 61 : 105 – 108 . 6 Konety BR Joslyn SA O'Donnell MA . Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: Analysis of data from the

Full access

William J. Catalona and Stacy Loeb

radical prostatectomy for stage T1c disease . Urology 2005 ; 66 : 156 – 160 . 9. Stephenson AJ Kattan MW Eastham JA . Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era

Full access

Philippe E. Spiess, Simon Horenblas, Lance C. Pagliaro, Matthew C. Biagioli, Juanita Crook, Peter E. Clark, Richard E. Greenberg and Cesar E. Ercole

Urology (EAU) and the International Consensus of the Société Internationale d’Urologie/International Consultation on Urological Diseases (SIU/ICUD). Epidemiology and Risk Factors Patients typically present with penile cancer between the ages of

Full access

Mark D. Tyson and Sam S. Chang

.D.T.). References 1. Tyson MD Humphreys MR Parker AS . Age-period-cohort analysis of renal cell carcinoma in United States adults . Urology 2013 ; 82 : 43 – 47 . 2. Motzer RJ Jonasch E Agarwal N . NCCN Clinical Practice Guidelines in Oncology

Full access

Mark H. Kawachi, Robert R. Bahnson, Michael Barry, J. Erik Busby, Peter R. Carroll, H. Ballentine Carter, William J. Catalona, Michael S. Cookson, Jonathan I. Epstein, Ruth B. Etzioni, Veda N. Giri, George P. Hemstreet III, Richard J. Howe, Paul H. Lange, Hans Lilja, Kevin R. Loughlin, James Mohler, Judd Moul, Robert B. Nadler, Stephen G. Patterson, Joseph C. Presti, Antoinette M. Stroup, Robert Wake and John T. Wei

prostate-specific antigen testing . Urology 2002 ; 60 : 756 – 759 . 9. Harris R Lohr KN . Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force . Ann Intern Med 2002 ; 137 : 917 – 929

Full access

Peter R. Carroll, J. Kellogg Parsons, Gerald Andriole, Robert R. Bahnson, Daniel A. Barocas, Erik P. Castle, William J. Catalona, Douglas M. Dahl, John W. Davis, Jonathan I. Epstein, Ruth B. Etzioni, Thomas Farrington, George P. Hemstreet III, Mark H. Kawachi, Paul H. Lange, Kevin R. Loughlin, William Lowrance, Paul Maroni, James Mohler, Todd M. Morgan, Robert B. Nadler, Michael Poch, Chuck Scales, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Preston Sprenke, Andrew J. Vickers, Robert Wake, Dorothy A. Shead and Deborah Freedman-Cass

-independent prostate cancer patients: a phase III trial (CALGB 9583) . J Clin Oncol 2004 ; 22 : 1025 – 1033 . 16. Barqawi A Gamito E O'Donnell C Crawford ED . Herbal and vitamin supplement use in a prostate cancer screening population . Urology 2004

Full access

Jeffrey S. Montgomery, David C. Miller and Alon Z. Weizer

of Urology (EAU) and American Urological Association (AUA) guidelines recommending a single perioperative dose of intravesical therapy after TURBT for low-grade Ta bladder cancer. Despite the data and guidelines, some evidence suggests that this

Full access

Ruben G.W. Quek, Kevin C. Ward, Viraj A. Master, Chun Chieh Lin, Kenneth M. Portier, Katherine S. Virgo and Joseph Lipscomb

Financing Administration (HCFA) specialty codes in Medicare claims, the physician specialty information from the AMAPM, or the urology board certification identified through the ABMS information within the AMAPM. Other urologist characteristics extracted

Full access

Hideki Furuya and Charles J. Rosser

“…for whom the bell tolls, It tolls for thee.” - John Donne The article, “It May be Time to Abandon Urine Tests for Bladder Cancer” 1 reinforces what is widely known within urology: that current urine-based assays for the diagnosis of

Full access

Stacy Loeb and H. Ballentine Carter

reason to maintain PSA values in the medical record. However, patients frequently present to the urology clinic with a listing of prior PSA data, and disregarding historical information is not a practicable option in the real-world clinical setting